Could Illinois become the 36th state that requires mammography providers to notify patients when it is determined they have dense breast tissue?

Researchers at Imperial College London and the University of Edinburgh have developed machine learning software that detects small vessel disease (SVD)—which can ultimately cause stroke.

Acetaminophen after pediatric heart surgery was associated with an increasingly protective effect against acute kidney injury (AKI), according to an analysis of separate cohorts at two children’s hospitals.

On May 17, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced the Value Initiative Industry Alliance—a collaboration among corporate community members that will help implement the organization’s Value Initiative and advance nuclear medicine.

AliveCor and Mayo Clinic have utilized machine learning to identify long QT syndrome (LQTS), with findings presented at the Heart Rhythm Scientific Sessions in Boston.

Researchers from Swansea University Medical School and the College of Human and Health Sciences have used electronic medical records (EMRs) to improve clinical trials by expanding remote monitoring. Findings were published May 16 in Scientific Reports.

Baylor St. Luke’s Medical Center in Houston continues to tout itself as one of the top heart transplant centers in the country, even as quality measures lag well behind national averages.

Only two percent of heavy smokers—those who smoke a pack a day—in the U.S. currently receive lung cancer screenings, according to a recent press release from the American Society of Clinical Oncology (ASCO).

Coronary CT angiography (CTA) is diagnostically accurate in detecting scaffold luminal obstruction, according to a team of international researchers, signaling it may become the preferred method for evaluating patients treated with bioresorbable vascular scaffold (BVS)—but not all experts agree.

The investigators of the anticipated ISCHEMIA trial have published a paper in Circulation: Cardiovascular Quality and Outcomes defending their late addition of “softer” outcomes to their primary composite endpoint.